The incidence of headaches in the patients with intracranial neo plasms varies from 33 to 71% [1]. The patients may present with symptoms that mimic a migraine, tension-type or a cluster headache [2]. The pain may be deep aching, intermittent and non-throbbing in quality, accompanied by nausea and vomiting which may occur in up to 36% of the patients [3].
Viderman, D., Nurpeissov, A., Bilotta, F. (2019). Intravenous lidocaine in the management of severe brain tumor-associated headache. JOURNAL OF CLINICAL ANESTHESIA, 55, 67-68 [10.1016/j.jclinane.2018.12.053].
Intravenous lidocaine in the management of severe brain tumor-associated headache
Bilotta, Federico
2019-01-01
Abstract
The incidence of headaches in the patients with intracranial neo plasms varies from 33 to 71% [1]. The patients may present with symptoms that mimic a migraine, tension-type or a cluster headache [2]. The pain may be deep aching, intermittent and non-throbbing in quality, accompanied by nausea and vomiting which may occur in up to 36% of the patients [3].File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2019 IvLido-JCA19.pdf
non disponibili
Licenza:
Copyright dell'editore
Dimensione
426.18 kB
Formato
Adobe PDF
|
426.18 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
